0001596062-17-000002.txt : 20170807 0001596062-17-000002.hdr.sgml : 20170807 20170807155425 ACCESSION NUMBER: 0001596062-17-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170807 DATE AS OF CHANGE: 20170807 EFFECTIVENESS DATE: 20170807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Q BioMed Inc. CENTRAL INDEX KEY: 0001596062 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 464013793 STATE OF INCORPORATION: NV FISCAL YEAR END: 1130 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-292272 FILM NUMBER: 171011430 BUSINESS ADDRESS: STREET 1: 501 MADISON AVE. STREET 2: 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 212-588-0022 MAIL ADDRESS: STREET 1: 501 MADISON AVE. STREET 2: 14TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 FORMER COMPANY: FORMER CONFORMED NAME: ISMO Tech Solutions, Inc. DATE OF NAME CHANGE: 20140107 D 1 primary_doc.xml X0708 D LIVE 0001596062 Q BioMed Inc. 501 MADISON AVE. 14TH FLOOR NEW YORK NY NEW YORK 10022 212-588-0022 NEVADA ISMO Tech Solutions, Inc. Corporation true 2013 Denis Corin 10 Market Street Suite 427 Grand Cayman E9 CAYMAN ISLANDS KY1-9006 Executive Officer Director President and Chief Executive Officer William S. Rosenstadt 501 Madison Avenue 14th Floor New York NY NEW YORK 10022 Executive Officer Director General Counsel Biotechnology No Revenues 06b false 2017-08-01 false true true false 0 Brookline Capital Markets, a division of CIM Securities, LLC 120852 None None 509 Madison Avenue 10th Floor New York NY NEW YORK 10022 CA CALIFORNIA CO COLORADO FL FLORIDA GA GEORGIA NJ NEW JERSEY WI WISCONSIN false 3050390 3050390 0 false 18 20260 true 102130 true 0 All proceeds are for working capital and general corporate purposes. The number above excludes use of proceeds for normal salary to be paid to persons required to be named in response to Item 3 above. false Q BioMed Inc. Denis Corin Denis Corin President and Chief Executive Officer 2017-08-07